CJC-1295 + Ipamorelin
CJC-1295 + Ipamorelin research peptide. Third-party Certificates of Analysis are published for tested products and batches. Fast UK dispatch. For laboratory research use only.
Available sizes: 10 mg
A Dual-Pathway Research Combination Studied in Growth Hormone Signalling and Endocrine Regulation
CJC-1295 + Ipamorelin combines two compounds studied for their roles in growth hormone (GH) signalling and endocrine pathway regulation.
In simple terms, this combination is explored in research examining how the body controls natural growth hormone release, signalling patterns, and hormonal balance through multiple regulatory mechanisms.
Because each compound targets a different signalling pathway, this pairing is commonly studied in laboratory models investigating pituitary stimulation, GH pulsatility, and integrated endocrine signalling.
Why This Combination Is Studied
Dual GH Signalling Pathways: Combines GHRH analogue signalling with ghrelin receptor activation.
Pulsatile GH Release Research: Studied for its role in mimicking natural growth hormone release patterns.
Selective Endocrine Signalling: Investigates GH stimulation with minimal interaction with other hormonal pathways.
Complementary Mechanisms: Explores how distinct regulatory systems interact within the GH axis.
Scientific Research Context
CJC-1295 is a growth hormone–releasing hormone (GHRH) analogue studied for its ability to stimulate the pituitary gland and promote growth hormone release via hypothalamic signalling pathways.
Ipamorelin is a selective growth hormone secretagogue investigated for activating the ghrelin receptor (GHS-R), which plays a role in regulating GH release and endocrine signalling.
Because these pathways operate through separate regulatory mechanisms, the combination is used in research environments to explore how GHRH signalling, ghrelin receptor activation, and growth hormone regulation may function together.
Common Research Focus Areas
Growth hormone secretion and pulsatility research
Endocrine system regulation studies
GH and IGF-1 signalling pathways
Pituitary function and hormone release models
Multi-pathway GH axis research
Related Peptides
This combination is studied within the broader category of compounds involved in growth hormone signalling and endocrine regulation.
Researchers exploring these mechanisms may also investigate compounds such as CJC-1295, Ipamorelin, GHRP-6, and Sermorelin, which are individually studied for their roles in growth hormone release and endocrine signalling pathways.
Documentation and verification
Certificates of Analysis are published for tested products and batches. A certificate is a batch-specific record: it reports what was measured, by which method, on a stated date, against a batch identifier. It is evidence about the sample analysed at the time of analysis, and it is silent on attributes it does not list and on what has happened to the material since.
The batch number is the field that connects the document to a physical vial. Where the identifier on a vial does not appear on a certificate, the certificate does not describe that vial, however thorough the analysis behind it was. Batch records can be searched directly, and the guides below explain what each field establishes and what it does not.
- Verify a batchSearch a batch number for the certificate records published against it.
- How to read a certificate of analysisWhat each field reports, and the limits of what a certificate can establish.
- Certificate, specification and safety data sheetThree documents that answer three different questions.
- Storage and handlingWhat defined storage conditions mean, and why cold slows degradation.
- Batch numbers and traceabilityHow an identifier ties material to the analysis describing it.
Supplied for laboratory research use only. Not for human or veterinary use.